BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 17530266)

  • 21. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata.
    Ito T; Aoshima M; Ito N; Uchiyama I; Sakamoto K; Kawamura T; Yagi H; Hashizume H; Takigawa M
    Arch Dermatol Res; 2009 Jun; 301(5):373-80. PubMed ID: 19301021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
    McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
    Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers.
    Hunter N; Shaker O; Marei N
    J Dermatolog Treat; 2011 Feb; 22(1):2-10. PubMed ID: 20524872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of transverse section scalp biopsy in alopecia areata - a clinicopathological correlation.
    Jameel K; Ejaz A; Sohail M; Rahman SB
    J Coll Physicians Surg Pak; 2008 Jun; 18(6):338-41. PubMed ID: 18760043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum.
    Zhang B; Zhao Y; Cai Z; Caulloo S; McElwee KJ; Li Y; Chen X; Yu M; Yang J; Chen W; Tang X; Zhang X
    Australas J Dermatol; 2013 Aug; 54(3):184-91. PubMed ID: 23808570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of cellular immunity against hair follicle melanocyte causes alopecia.
    Nagai H; Oniki S; Oka M; Horikawa T; Nishigori C
    Arch Dermatol Res; 2006 Aug; 298(3):131-4. PubMed ID: 16786344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients.
    Yano S; Nakamura K; Okochi H; Tamaki K
    Acta Derm Venereol; 2002; 82(2):82-5. PubMed ID: 12125957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
    Sato-Kawamura M; Aiba S; Tagami H
    Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of alopecia areata with diphencyprone].
    Suditu G; Toma A; Voiculescu M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):760-2. PubMed ID: 12092234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
    Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
    J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cicatricial marginal alopecia: is it all traction?
    Goldberg LJ
    Br J Dermatol; 2009 Jan; 160(1):62-8. PubMed ID: 18811691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Selective changes in lymphocytic differentiation antigens in the peripheral blood of patients with alopecia areata treated with oral zinc].
    Lutz G; Kreysel HW
    Z Hautkr; 1990 Feb; 65(2):132-4, 137-8. PubMed ID: 1971470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Videocapillaroscopic pattern of alopecia areata before and after diphenylciclopropenone treatment.
    Ganzetti G; Campanati A; Simonetti O; Cataldi I; Giuliodori K; Offidani AM
    Int J Immunopathol Pharmacol; 2011; 24(4):1087-91. PubMed ID: 22230416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of widespread non-pigmented hair regrowth in diffuse alopecia areata.
    Dinh QQ; Chong AH
    Australas J Dermatol; 2007 Nov; 48(4):221-3. PubMed ID: 17956479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulse corticosteroid therapy for alopecia areata: study of 139 patients.
    Nakajima T; Inui S; Itami S
    Dermatology; 2007; 215(4):320-4. PubMed ID: 17911990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology.
    Ito T; Bertolini M; Funakoshi A; Ito N; Takayama T; Biro T; Paus R; Tokura Y
    J Dermatol Sci; 2013 Dec; 72(3):327-30. PubMed ID: 24001790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.